The Scientist - Home

A new facility located in a congested community with high tuberculosis rates brings basic science and cutting edge techniques into the heart of disease circulation.

Overall, men received more money on average, but R01s were an exception.

Uncertainties about the cells’ risk profiles and the potential for hyping unproven therapies mean scientists and the media must tread carefully.

The US Department of the Interior determined that the population has rebounded enough to no longer need Endangered Species Act protection; conservation biologists disagree.

After attacks on two Ebola treatment centers in Democratic Republic of Congo last week, Doctors Without Borders says public health workers are “failing” to control the epidemic.

Neurons can only efficiently fix genetic injuries when the animals are asleep.

The nasal spray to ease intractable depression appears on the US market after decades without novel antidepressant treatments.

T cells modified to target disease-contributing B cells improved survival in two mouse models of the autoimmune disease.

Animal and cell culture studies show evidence that dengue antibodies can both neutralize and enhance Zika, but human investigations have only found protective effects.

Gottlieb will step down after two years at the helm of the US Food and Drug Administration to spend more time with his family.

A pilot project between the scholarly publisher and the academic networking platform launched last week.

The “London patient” may represent the second person cured of the infection by a cell transplant.